While Mounjaros primary indication is for type 2 diabetes, it demonstrates promising weight loss results
Kris Dilley, RDN, notes that weight loss medications can curb appetite and reduce food intake, and some animal research suggests they may also suppress water drinking
Common question patients ask when starting BPC-157: 250 mcg of BPC-157 = How Many Units
Both are effective, both are FDA-approved, and both are widely prescribed
The Long Term Effects of Semaglutide - A Two Year Study Lindsey Wood Feb 6, 2024 9 min read Behavioral strategies adjusting dietary habits and physical activity constitute the cornerstone of addressing overweight and obesity
Mounjaro, made by drug company Eli Lilly, is classified as a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist, also called a dual GIP/GLP-1 agonist